<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="50114">Estrogen</z:chebi> has been shown to protect against <z:hpo ids='HP_0001297'>stroke</z:hpo>-induced brain damage, yet the mechanism is unknown </plain></SENT>
<SENT sid="1" pm="."><plain>During the early hours of <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> forms as increased transport of Na and Cl from blood into brain occurs across an intact blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain>We showed previously that a <z:chebi fb="2" ids="8069">luminal</z:chebi> <z:chebi fb="2" ids="33602">BBB</z:chebi> Na-K-Cl cotransporter is stimulated by <z:mp ids='MP_0005039'>hypoxia</z:mp> and arginine vasopressin (AVP), factors present during <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, and that inhibition of the cotransporter by intravenous bumetanide greatly reduces <z:hpo ids='HP_0000969'>edema</z:hpo> in rats subjected to permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="3" pm="."><plain>The present study was conducted to determine whether <z:chebi fb="0" ids="50114">estrogen</z:chebi> protects in <z:hpo ids='HP_0001297'>stroke</z:hpo> at least in part by reducing activity of the <z:chebi fb="2" ids="33602">BBB</z:chebi> cotransporter, thereby decreasing <z:hpo ids='HP_0000969'>edema</z:hpo> formation </plain></SENT>
<SENT sid="4" pm="."><plain>Ovariectomized rats were subjected to 210 mins of permanent MCAO after 7-day or 30-min pretreatment with <z:chebi fb="0" ids="16469">17beta-estradiol</z:chebi> and then <z:e sem="disease" ids="C1527311" disease_type="Disease or Syndrome" abbrv="">brain swelling</z:e> and 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining were assessed as measures of <z:hpo ids='HP_0002181'>brain edema</z:hpo> and lesion volume, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Diffusion-weighed imaging was used to monitor permanent MCAO-induced decreases in apparent diffusion coefficient (<z:chebi fb="49" ids="35181">ADC</z:chebi>) values, an index of changes in brain water distribution and mobility </plain></SENT>
<SENT sid="6" pm="."><plain>Na-K-Cl cotransporter activity of cerebral microvascular endothelial cells (CMECs) was assessed as bumetanide-sensitive K influx and cotransporter abundance by Western blot analysis after <z:chebi fb="1" ids="23965">estradiol</z:chebi> treatment </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="1" ids="23965">Estradiol</z:chebi> significantly decreased <z:e sem="disease" ids="C1527311" disease_type="Disease or Syndrome" abbrv="">brain swelling</z:e> and lesion volume and attenuated the decrease in <z:chebi fb="49" ids="35181">ADC</z:chebi> values during permanent MCAO </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="1" ids="23965">Estradiol</z:chebi> also abolished CMEC cotransporter stimulation by chemical <z:mp ids='MP_0005039'>hypoxia</z:mp> or AVP and decreased cotransporter abundance </plain></SENT>
<SENT sid="9" pm="."><plain>These findings support the hypothesis that <z:chebi fb="0" ids="50114">estrogen</z:chebi> attenuates stimulation of <z:chebi fb="2" ids="33602">BBB</z:chebi> Na-K-Cl cotransporter activity, reducing <z:hpo ids='HP_0000969'>edema</z:hpo> formation during <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>